Nature Research has teamed up with the Scripps Translational Institute to launch a new journal focused on digital medicine. The journal, npj Digital Medicine is under the Nature Partner Journal Series and the editorial tutelage of Dr. Eric Topol, professor of genomics and founder of the STSI and Dr. Steven Steinhubl, director of digital medicine at Scripps Health.
Moving from digital health hype to evidence
The mission of the journal as described in its flagship editorial aims to move digital medicine from hype to evidence.
Our enthusiasm for the future of digital medicine is tempered by the recognition that presently too much of the publicized work in this field is characterized by irrational exuberance and excessive hype. Many technologies have yet to be formally studied in a clinical setting, and for those that have, too many began and ended with an under-powered pilot program. In addition, there are more than a few examples of digital “snake oil” with substantial uptake prior to their eventual discrediting. Both of these practices are barriers to advancing the field of digital medicine.
Why npj Digital Medicine is a significant step in digital health
The first digital medicine repository. This is the first reputable hub for clinical trials and studies related to digital medicine.
Npj Digital Medicine takes digital health back from the marketers. In a world of digital health hijacked by marketeers, this journal raises the bar and marks the start of a new era of evidence in digital health. In a hype-defying move this flagship edition features a meta-analysis of randomized control trials on remote patient monitoring that shows there’s a lot more work to do.
Community is included. Beyond a fully functioning peer-reviewed publication there is an associated npj Digital Medicine Community built to foster collaboration between researchers, clinicians and patients.
It’s free. True to its commitment to democratized medicine, there’s no paywall.
This one is at the top of my Feedly feed. Stay tuned.